At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks Almost 40% of patients had no more than one active lesion after 12 weeks of berdazimer gel Mar 23, 2023
Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist Rapid reduction in itch, sleep disturbance, nodules after first dose of nemolizumab Mar 22, 2023
FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
Durable Vitiligo Responses With Topical Ruxolitinib Responses often maintained after drug withdrawal, long-term persistence with ongoing treatment Mar 21, 2023
High Rates of Psoriasis Clearance With Investigational TYK2 Inhibitor Rates of 90% clearance approaching 50% at 12 weeks, with 100% clearance rates as high as 33% Mar 21, 2023
Rapid Improvement in Atopic Dermatitis With Topical PDE4 Inhibitor Disease status, itch improved significantly within 1 to 2 weeks with roflumilast cream Mar 20, 2023
Cases of Bald Spots After Regular Use of Detangling Hairbrushes A report of three cases of trichomalacia in young women Mar 20, 2023
Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies New analyses show "unprecedented" rates of 50% to 100% improvement Mar 20, 2023
Another Win for a JAK Inhibitor in Alopecia Areata About 40% of patients go from nearly hairless to almost a full head of hair with deuruxolitinib Mar 19, 2023
Biologic Switch Revs Up Response in Plaque Psoriasis "Dramatic improvement" at 16 weeks with IL-23 blocker after lack of response to anti-IL-17 drug Mar 19, 2023
New Lupus Drug Cuts Skin Disease When Other Agents Fail Small study backs anifrolumab for salvage therapy Mar 15, 2023
Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years Diagnosis implicates high triglycerides as a contributor Mar 13, 2023
Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant Randomized study finds no benefit with 12 months of nicotinamide versus placebo Mar 01, 2023
Psoriatic Arthritis: Depressing News on Second- and Later-Line Treatments Real-world data indicate most patients who fail a first biologic drug never obtain remission Feb 27, 2023
Make the Diagnosis: Why Are These Lumps Here? A 33-year-old woman went to the doctor after noticing painful lumps on her legs that had developed over the past few days, some of which had begun to drain pus. Can you diagnose the patient? Feb 23, 2023
Childhood Eczema Rose in Past Two Decades, With Unexplained Racial Divides Black and multiracial children had the greatest increases in eczema Feb 22, 2023
Dupilumab Delivers in Erythrodermic Atopic Dermatitis Key clinical outcomes, inflammatory biomarkers significantly reduced with or without steroids Feb 13, 2023
Oral Drug Shows Benefit for Notalgia Paresthetica in Mid-Stage Trial Phase II study hits primary endpoint, but researchers call for larger and longer trials Feb 08, 2023
Moderna Booster Vaccine Singled Out for Chronic Hives Chronic spontaneous urticaria more frequent when compared with Pfizer's mRNA vaccine Feb 01, 2023
High Rates of Psychiatric Disorders in Patients With Alopecia Areata Two to three times higher than the general population, many more with suggestive symptoms Jan 31, 2023
Woman Seeks Answers After 3 Years of Painful Genital Ulcers Histopathology reveals a disease most often seen in young children Jan 30, 2023
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips? The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis Jan 23, 2023
IL-13 Blocker Beats Atopic Dermatitis With favorable results from three trials, approval seems likely Jan 11, 2023
UCSF's Unethical Experiments; Mystery of Doc Lost at Sea; Ketamine Via Telehealth This past week in healthcare investigations Jan 04, 2023
5-ARIs Not Linked to Risk of Dementia Over the Long Term However, finasteride and dutasteride were associated with an increased risk of depression Dec 22, 2022
Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma Encorafenib-binimetinib tops vemurafenib, but checkpoint inhibitors remain first-line choice Dec 19, 2022
Topical Gene Therapy Heals Blistering Skin Disease Lesions Randomized trial shows "dramatic" benefits in rare genetic disease Dec 14, 2022
Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
What's Behind Boy's Bullous Skin Lesions After Flu Symptoms? Mycoplasma pneumonia identified as the culprit in this case of RIME Nov 28, 2022
Large U.S. Study Finds No Link Between COVID Vaccine and Shingles Findings add new evidence to conflicting prior reports Nov 16, 2022
Melanoma Resistant to Anti-PD-1 Responds to Tumor Infiltrating Lymphocytes Almost a third of patients had objective responses, which deepened over time, study showed Nov 16, 2022
New Treatment Options on the Horizon for Chronic Spontaneous Urticaria Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short Nov 16, 2022
Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Response Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning Nov 14, 2022
Terry Bradshaw's Merkel Cell Carcinoma After beating bladder cancer, the Hall of Fame quarterback was diagnosed with a rare skin tumor Nov 10, 2022
Maralixibat Takes Out the Itch of Rare Liver Disease Ileal bile acid transporter inhibitor could become second drug for PFIC Nov 09, 2022
Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devices Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
Pebbled Skin and Excessive Hair Growth on a 5-Year-Old's Back Just two of the multiple symptoms that began to emerge shortly after birth Oct 24, 2022
Dupilumab Gets First FDA-Approved Indication for Prurigo Nodularis Significant improvement in itch and nodules at 24 weeks seen in two randomized trials Sep 29, 2022
Immunotherapy First for BRAF Melanoma Edges Out Targeted Combination "Clinically meaningful" improvement in 2- and 3-year survival Sep 28, 2022
